Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong

References

• Davies HD, McGeer A, Schwartz B, et al Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335: 547–54.
   PubMed Web of Science ®Google Scholar
• Ho PL, Johnson DR, Yu AWY, et al Epidemiological analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J Clin Microbiol 2003; 41: 937–42.
   PubMed Web of Science ®Google Scholar
• Li Z, Sakota V, Jackson D, et al Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis 2003; 188: 1587–92.
   PubMed Web of Science ®Google Scholar
• Hsueh PR, Wu JJ, Tsai PJ, et al Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998; 26: 584–9.
   PubMed Web of Science ®Google Scholar
• Lamgni TL, Neal S, Keshishian C, et al Severe Streptococcus pyogenes infection, United Kingdom, 2003–2004. Emerg Infect Dis 2008; 14: 201–9.
   Web of Science ®Google Scholar
• Darenberg J, Luca-Harari B, Jasir A, et al Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45: 450–8.
   PubMed Web of Science ®Google Scholar
• O'Loughlin RE, Roberson A, Cieslak PR, et al The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 2007; 45: 853–62.
   PubMed Web of Science ®Google Scholar
• Luca-Harari B, Ekellund K, van der Linden M, et al Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 2008; 46: 79–86.
   PubMed Web of Science ®Google Scholar
• Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411–26.
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511.
   PubMed Web of Science ®Google Scholar
• Norrby-Teglund A, Pauksens K, Holm SE, et al Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis 1994; 170: 585–91.
   PubMed Web of Science ®Google Scholar
• Bisno AL, Rubin FA, Cleary PP, et al Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles – report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 2005; 41: 1150–6.
   PubMed Web of Science ®Google Scholar
• McNeil SA, Halperin SA, Langley JM, et al Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41: 1114–22.
   PubMed Web of Science ®Google Scholar
• Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34: 953–8.
   PubMed Web of Science ®Google Scholar
• Hashikawa S, Iinuma Y, Furushita M, et al Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004; 42: 186–92.
   PubMed Web of Science ®Google Scholar
• Chatellier S, Ihendyane N, Kansal RG, et al Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000; 68: 3523–34.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 17th Informational Supplement. CLSI document M100-S17. Wayne, PA: CLSI, 2007.
   Google Scholar
• Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10: 55–7.
   PubMed Web of Science ®Google Scholar
• Factor SH. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003; 9: 970–7.
   PubMed Web of Science ®Google Scholar
• Smith AT, Lamagni I, Oliver A, et al Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect Dis 2005; 5: 494–500.
   PubMed Web of Science ®Google Scholar
• Factor SH, Levine OS, Harrison LH, et al Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11: 1062–6.
   PubMed Web of Science ®Google Scholar
• Steer AC, Jenney AJW, Oppedisano F, et al High burden of invasive β-haemolytic streptococcal infections in Fiji. Epidemiol Infect 2008; 136: 621–7.
   PubMed Web of Science ®Google Scholar
• Jing H, Ning B, Hao H, et al Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol 2006; 55: 1101–7.
   PubMed Web of Science ®Google Scholar
• Creti R, Imperi M, Baldassarri L, et al emm types, virulence factors, and antibiotic resistace of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 2007; 45: 2249–56.
   PubMed Web of Science ®Google Scholar
• Wahl RU, Lütticken R, Stanzel S, et al Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system. Clin Microbiol Infect 2007; 13: 1173–8.
   PubMed Web of Science ®Google Scholar
• Ikebe T, Hirasawa K, Suzuki R, et al Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal infections in Japan, 2001–2005. Epidemiol Infect 2007; 135: 1227–9.
   PubMed Web of Science ®Google Scholar
• Hu MC, Walls MA, Stroop SD, et al Immunogenicity of a 26-Valent group A streptococcal vaccine. Infect Immun 2002; 70: 2171–7.
   PubMed Web of Science ®Google Scholar
• Szczypa K, Sadowy E, Izdebski R, et al Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 2006; 44: 3975–9.
   PubMed Web of Science ®Google Scholar
• Schmitz FJ, Beyer A, Charpentier E, et al Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 2003; 188: 1578–86.
   PubMed Web of Science ®Google Scholar
• Bae SY, Kim JS, Kwon J, et al Phenotypes and genotypes of macrolide-resistance Streptococcus pyogenes isolated in Seoul, Korea. J Med Microbiol 2007; 56: 229–35.
   PubMed Web of Science ®Google Scholar
• Rivera A, Rebollo M, Miró E, et al Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 2006; 55: 1115–23.
   PubMed Web of Science ®Google Scholar
• Krucsó B, Gacs M, Libisch B, et al Molecular characterization of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur J Clin Microbiol Infect Dis 2007; 26: 807–11.
   PubMed Web of Science ®Google Scholar
• Liang Y, Shen X, Huang G, et al Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever. Acta Paediatr 2008; 97: 1681–5.
   PubMed Web of Science ®Google Scholar